accountRoche Holding AG and Daiichi Sankyo Co. won U.S. clearance to sell a pill for melanoma that is among a new wave of medicines developed to fight the deadliest form of skin cancer.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Roche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account